Processa Pharmaceuticals (PCSA) EBIT Margin (QoQ) (2012 - 2016)
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) EBIT Margin (QoQ) (2012 - 2016) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Processa Pharmaceuticals | 5.75 Mn | 5.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | -26,955.00 |
| Dec 31, 2015 | -102,605.00 |
| Sep 30, 2015 | 917,479.00 |
| Jun 30, 2015 | -817,556.00 |
| Mar 31, 2015 | 355,045.00 |
| Dec 31, 2014 | -350,672.00 |
| Sep 30, 2014 | -60,338.00 |
| Jun 30, 2014 | 563,017.00 |
| Mar 31, 2014 | -515,367.00 |
| Dec 31, 2013 | -59,513.00 |
| Sep 30, 2013 | 17,695.00 |
| Jun 30, 2013 | 345,989.00 |
| Mar 31, 2013 | -173,200.00 |
| Dec 31, 2012 | -128,247.00 |
| Sep 30, 2012 | -74,042.00 |